|
CA2809515A1
|
|
Composition for inducing pluripotent stem cell, and use thereof
|
|
EP2351599A1
|
|
Method for producing dendritic cells
|
|
WO2010050586A1
|
|
Method for enhancing expression of recombinant protein
|
|
WO2010050585A1
|
|
Vector for treating alzheimer's disease
|
|
KR20100035634A
|
|
Method for production of dendritic cell
|
|
WO2008133206A1
|
|
Non-replicating paramyxoviridae virus vector
|
|
US2010323428A1
|
|
Attenuated minus-stranded rna virus
|
|
KR20090052857A
|
|
Non-replicating paramyxoviridae virus vector
|
|
EP2034014A1
|
|
Therapeutic agent for alzheimer's disease
|
|
CN101495631A
|
|
Therapeutic agent for Alzheimer's disease
|
|
CN101405389A
|
|
Novel protein expression system
|
|
KR20080065675A
|
|
Therapeutic method for blood coagulation disorder
|
|
WO2006137517A1
|
|
Vector for gene transfer into young individual
|
|
KR20080016955A
|
|
Method for production of antibody
|
|
CN101243179A
|
|
Method for production of antibody
|
|
EP1891215A2
|
|
Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
|
|
CN101228272A
|
|
Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
|
|
WO2006090697A1
|
|
Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing pedf and fgf2
|
|
WO2006090689A1
|
|
Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of siv-pedf vector
|
|
JP2008105946A
|
|
Method of reconstructing blood cell from gene-transfer hematopoietic cell
|
